Published in Drug Law Weekly, April 5th, 2011
"This paper uses data from the Indian pharmaceutical industry to develop a structural model of demand, supply and entry. The estimation yields demand and supply parameters that indicate significant heterogeneity among firms both within and across different therapeutic segments," wrote A. Dutta and colleagues.
The researchers concluded: "The estimated parameters are used to simulate patent enforcement and price deregulation...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.